Jacqueline Duffour
Overview
Explore the profile of Jacqueline Duffour including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
576
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Palassin P, Lapierre M, Pyrdziak S, Wagner A, Stehle R, Corsini C, et al.
Cancers (Basel)
. 2021 Sep;
13(17).
PMID: 34503257
Microsatellite instability (MSI) is related to the alteration of mismatch repair (MMR) genes and plays a key role in colorectal cancer (CRC) pathogenesis. We previously reported that the transcription factor...
2.
Boissiere-Michot F, Frugier H, Ho-Pun-Cheung A, Lopez-Crapez E, Duffour J, Bibeau F
Virchows Arch
. 2016 May;
469(2):135-44.
PMID: 27220764
DNA mismatch repair (MMR) protein analysis by immunohistochemistry (IHC) can identify colorectal cancer (CRC) with microsatellite instability (MSI). As MLH1-deficient CRC can be hereditary or sporadic, markers to distinguish between...
3.
Duffour J, Combes A, Crapez E, Boissiere-Michot F, Bibeau F, Senesse P, et al.
J Genet Couns
. 2015 Sep;
25(3):432-42.
PMID: 26392361
Reproductive techniques such as prenatal diagnosis (PND) or preimplantation genetic diagnosis (PGD), although debated, are legally forbidden in France in case of Lynch syndrome. The preference of mutation carriers about...
4.
Baert-Desurmont S, Charbonnier F, Houivet E, Ippolito L, Mauillon J, Bougeard M, et al.
Eur J Hum Genet
. 2015 Apr;
24(1):99-105.
PMID: 25873010
To determine if the at-risk single-nucleotide polymorphism (SNP) alleles for colorectal cancer (CRC) could contribute to clinical situations suggestive of an increased genetic risk for CRC, we performed a prospective...
5.
Boissiere-Michot F, Lazennec G, Frugier H, Jarlier M, Roca L, Duffour J, et al.
Oncoimmunology
. 2014 Aug;
3:e29256.
PMID: 25101223
Sporadic or hereditary colorectal cancer (CRC) with microsatellite instability (MSI) is frequently characterized by inflammatory lymphocytic infiltration and tends to be associated with a better outcome than microsatellite stable (MSS)...
6.
Nougaret S, Rouanet P, Molinari N, Pierredon M, Bibeau F, Azria D, et al.
Radiology
. 2012 Mar;
263(2):409-18.
PMID: 22438364
Purpose: To retrospectively determine whether magnetic resonance (MR) volumetry of rectal cancer is a reproducible method for predicting disease-free survival (DFS) in patients with locally advanced low or midrectal tumors...
7.
Bonadona V, Bonaiti B, Olschwang S, Grandjouan S, Huiart L, Longy M, et al.
JAMA
. 2011 Jun;
305(22):2304-10.
PMID: 21642682
Context: Providing accurate estimates of cancer risks is a major challenge in the clinical management of Lynch syndrome. Objective: To estimate the age-specific cumulative risks of developing various tumors using...
8.
Duffour J, Thezenas S, Dereure O, Garcin A, Caron J, Samalin E, et al.
Eur J Cancer
. 2010 Apr;
46(18):3169-74.
PMID: 20417092
The aim of this study was to measure the inter-observer agreement between two teams of three dermatologists and oncologists in labelling and grading the cetuximab-induced dermatological toxicities from 98 photographs...
9.
Poujol S, Pinguet F, Ychou M, Abderrahim A, Duffour J, Bressolle F
Oncol Rep
. 2007 Nov;
18(6):1613-321.
PMID: 17982652
In this study we propose for the first time a limited sampling strategy to estimate the individual pharmacokinetic parameters of both irinotecan and SN-38 in patients treated with the irinotecan...
10.
Duffour J, Gourgou S, Desseigne F, Debrigode C, Mineur L, Pinguet F, et al.
Cancer Chemother Pharmacol
. 2006 Nov;
60(3):383-9.
PMID: 17124595
Purpose: Irinotecan at 180 mg/m2 combined with an infusional 5-fluorouracil/leucovorin (5-FU/LV) regimen (FOLFIRI) is a standard first line therapy for metastatic colorectal cancer (mCRC). This phase II study aimed to...